Profound Medical Corp.
PRN.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.72M | -5.33M | -9.36M | -6.92M | -6.59M |
| Total Depreciation and Amortization | 163.00K | 212.00K | 223.00K | 242.00K | 250.00K |
| Total Amortization of Deferred Charges | -- | -136.00K | 45.00K | 45.00K | -- |
| Total Other Non-Cash Items | 1.28M | -566.00K | 730.00K | 956.00K | 750.00K |
| Change in Net Operating Assets | 998.00K | 182.00K | 2.00M | -674.00K | 1.06M |
| Cash from Operations | -8.28M | -5.64M | -6.36M | -6.35M | -4.53M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -290.00K | -523.00K | -665.00K | -676.00K | -623.00K |
| Issuance of Common Stock | -- | 39.21M | 0.00 | 1.00K | 22.94M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -3.04M | 0.00 | 0.00 | -1.86M |
| Cash from Financing | -290.00K | 35.65M | -665.00K | -675.00K | 20.46M |
| Foreign Exchange rate Adjustments | 94.00K | -2.22M | 72.00K | -76.00K | -960.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.48M | 27.79M | -6.96M | -7.10M | 14.97M |